Multimorbidity and rheumatic conditions - Enhancing the concept of comorbidity

Nature Reviews Rheumatology

Volumn 10, Issue 4, 2014, Pages 252-256

  Radner, Helga ^a   Yoshida, Kazuki ^a   Smolen, Josef S ^b   Solomon, Daniel H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; TUMOR NECROSIS FACTOR INHIBITOR;

AGING; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL ASSESSMENT; COMORBIDITY; DISEASE ASSOCIATION; HEALTH CARE COST; HUMAN; MEDICAL DECISION MAKING; MEDICARE; MORBIDITY; MULTIMORBIDITY; OSTEOPOROSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; RESOURCE ALLOCATION; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT PLANNING;

COMORBIDITY; DECISION MAKING; HUMANS; PATIENT CARE; RHEUMATIC DISEASES; RHEUMATOLOGY;

EID: 84898597459     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2013.212     Document Type: Review

References (48)

1. Barnett, K. et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380, 37-43 (2012).
2. Diederichs, C., Berger, K. & Bartels, D. B. The measurement of multiple chronic diseases-a systematic review on existing multimorbidity indices. J. Gerontol. A Biol. Sci. Med. Sci. 66, 301-311 (2010).
3. Fortin, M., Stewart, M., Poitras, M. E., Almirall, J. & Maddocks, H. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann. Fam. Med. 10, 142-151 (2012).
4. Redelmeier, D. A., Tan, S. H. & Booth, G. L. The treatment of unrelated disorders in patients with chronic medical diseases. N. Engl. J. Med. 338, 1516-1520 (1998).
5. Uijen, A. A. & van de Lisdonk, E. H. Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur. J. Gen. Pract. 14 (Suppl. 1), 28-32 (2008).
6. Fortin, M., Lapointe, L., Hudon, C. & Vanasse, A. Multimorbidity is common to family practice: is it commonly researched? Can. Fam. Physician 51, 244-245 (2005).
7. Feinstein, A. The pre/therapeutic classification of co/morbidity in chronic disease. J. Chron. Dis. 23, 455-469 (1970).
8. Gabriel, S. E., Crowson, C. S. & O?Fallon, W. M. Comorbidity in arthritis. J. Rheumatol 26, 2475-2479 (1999).
9. Michaud, K. & Wolfe, F. Comorbidities in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 21, 885-906 (2007).
10. Norton, S. et al. A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology (Oxford) 52, 99-110 (2012).
11. Huscher, D. et al. Clinical presentation, burden of disease and treatment in young-onset and late-onset rheumatoid arthritis: a matched-pairs analysis taking age and disease duration into account. Clin. Exp. Rheumatol. 31, 256-262 (2013).
12. Allebeck, P., Ahlbom, A. & Allander, E. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate. Eleven-year follow-up of an epidemiological study. Scand. J. Rheumatol. 10, 301-306 (1981).
13. Berkanovic, E. & Hurwicz, M. L. Rheumatoid arthritis and comorbidity. J. Rheumatol 17, 888-892 (1990).
14. Goodson, N. J. et al. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum. 46, 2010-2019 (2002).
15. Naz, S. M. & Symmons, D. P. Mortality in established rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 21, 871-883 (2007).
16. Radner, H., Smolen, J. S. & Aletaha, D. Impact of comorbidity on physical function in patients with rheumatoid arthritis. Ann. Rheum. Dis. 69, 536-541 (2009).
17. Radner, H., Smolen, J. S. & Aletaha, D. Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis. Rheumatology (Oxford) 50, 381-388 (2010).
18. Lakomek, H. J., Brabant, T., Lakomek, M. & Luttje, D. Multimorbidity in elderly rheumatic patients part 1 [German]. Z. Rheumatol. 72, 530-538 (2013).
19. Lakomek, H. J., Brabant, T., Lakomek, M. & Luttje, D. Multimorbidity in elderly rheumatic patients part 2 [German]. Z. Rheumatol 72, 539-546 (2013).
20. Campbell-Scherer, D. Multimorbidity: a challenge for evidence-based medicine. Evid. Based Med. 15, 165-166 (2010).
21. Schellevis, F. G., van Eijk, J. T., van den Lisdonk, E. H., vd Velden, J. & van Weel, C. Implementing guidelines in general practice. Evaluation of process and outcome of care in chronic diseases. Int. J. Qual. Health Care 6, 257-266 (1994).
22. Schellevis, F. G., van der Velden, J., van de Lisdonk, E., van Eijk, J. T. & van Weel, C. Comorbidity of chronic diseases in general practice. J. Clin. Epidemiol. 46, 469-473 (1993).
23. van den Akker, M. Comorbidity or multimorbidity: what?s in a name? Eur. J. Gen. Pract. 2, 65-70 (1996).
24. Loza, E., Jover, J. A., Rodriguez, L. & Carmona, L. Multimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease. Semin. Arthritis Rheum. 38, 312-319 (2009).
25. Anderson, G. Chronic conditions: Making the case for ongoing care [online], http://www.partnershipforsolutions.org/DMS/files/chronicbook2004.pdf.
26. Librero, J., Peiro, S. & Ordinana, R. Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days. J. Clin. Epidemiol. 52, 171-179 (1999).
27. Greenfield, S., Apolone, G., McNeil, B. J. & Cleary, P. D. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med. Care 31, 141-154 (1993).
28. Menotti, A. et al. Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly). J. Clin. Epidemiol. 54, 680-686 (2001).
29. Roversi, S., Roversi, P., Spadafora, G., Rossi, R. & Fabbri, L. M. Coronary artery disease concomitant with chronic obstructive pulmonary disease. Eur. J. Clin. Invest. 44, 93-102 (2014).
30. Schafer, I. et al. The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. First results from the multicare cohort study. BMC Health Serv. Res. 12, 89 (2012).
31. Booth, H. P., Prevost, A. T. & Gulliford, M. C. Impact of body mass index on prevalence of multimorbidity in primary care: cohort study. Fam. Pract. http://dx.doi.org/10.1093/fampra/cmt061.
32. Marengoni, A. & Fratiglioni, L. Disease clusters in older adults: rationale and need for investigation. J. Am. Geriatr. Soc. 59, 2395-2396 (2011).
33. Schafer, I. et al. Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS ONE 5, e15941 (2011).
34. Schafer, I. Does multimorbidity influence the occurrence rates of chronic conditions? A claims data based comparison of expected and observed prevalence rates. PLoS ONE 7, e45390 (2012).
35. van den Akker, M., Buntinx, F., Roos, S. & Knottnerus, J. A. Problems in determining occurrence rates of multimorbidity. J. Clin. Epidemiol. 54, 675-679 (2001).
36. van den Akker, M., Buntinx, F., Metsemakers, J. F. & Knottnerus, J. A. Marginal impact of psychosocial factors on multimorbidity: results of an explorative nested case-control study. Soc. Sci. Med. 50, 1679-1693 (2000).
37. Hoffman, C., Rice, D. & Sung, H. Y. Persons with chronic conditions. Their prevalence and costs. JAMA 276, 1473-1479 (1996).
38. Wolff, J. L., Starfield, B. & Anderson, G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch. Intern. Med. 162, 2269-2276 (2002).
39. van den Bussche, H. et al. Patterns of ambulatory medical care utilization in elderly patients with special reference to chronic diseases and multimorbidity-results from a claims data based observational study in Germany. BMC Geriatr. 11, 54 (2011).
40. Smolen, J. S. et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann. Rheum. Dis. 69, 631-637 (2010).
41. Adams, A. J. et al. Report of the AACP Task Force on Patient-Centered Medical Homes and accountable care organizations. Am. J. Pharm. Educ 77, 142 (2013).
42. Helfgott, A. W. The patient-centered medical home and accountable care organizations: an overview. Curr. Opin. Obstet. Gynecol. 24, 458-464 (2012).
43. Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann. Rheum. Dis. http://dx.doi.org/10.1136/ annrheumdis-2013-204573.
44. Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann. Rheum. Dis. 69, 964-975 (2010).
45. Boyd, C. M. et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 294, 716-724 (2005).
46. Drossaers-Bakker, K. W., Kroon, H. M., Zwinderman, A. H., Breedveld, F. C. & Hazes, J. M. Radiographic damage of large joints in long-term rheumatoid arthritis and its relation to function. Rheumatology (Oxford) 39, 998-1003 (2000).
47. Welsing, P. M., van Gestel, A. M., Swinkels, H. L., Kiemeney, L. A. & van Riel, P. L. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum. 44, 2009-2017 (2001).
48. Iannaccone, C. K. et al. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women?s Hospital Rheumatoid Arthritis Sequential Study. Rheumatology (Oxford) 50, 40-46 (2010).